Pegasystems enters its third-quarter report with an unusual setup: a stock that has rallied hard on the heels of one of its most sobering conference calls in recent memory. Last quarter, management told investors that growth in annual contract value, the company's core health metric, had roughly halved, that the first-half shortfall would be very difficult to recover, and that its $575 million free cash flow target was now under pressure. Since then the shares have climbed about 41%, far ahead of the S&P 500's 4% gain. The market has effectively decided that the second quarter marked the bottom. This report will show whether that bet was early or simply wrong.
On the headline numbers, Wall Street expects non-GAAP earnings of $0.45 per share on revenue of about $442.6 million, which would represent roughly 16% growth from the year-ago quarter's $381.4 million. That is a healthy top-line pace and a big step up from last quarter's $0.18 in EPS, but the comparison needs context. Management flagged a renewal book weighted toward the back half of the year, so a revenue jump in the third quarter partly reflects calendar timing rather than fresh demand. The Earnings Whisper sits at $0.48, a few cents above consensus, implying that the more engaged crowd expects a modest beat. Clearing the EPS bar on renewal-driven revenue is plausible; it just will not settle the debate.
The number that matters most is ACV. Growth slowed to 7% reported, or 8% in constant currency, in the second quarter, down from around 14% in constant currency exiting the first quarter and 17% reported at the end of fiscal 2025. PegaCloud ACV growth cooled to 22% from 29% a quarter earlier, snapping a stretch of acceleration that had defined the bull case through 2025. Management blamed a mix of renewal timing, buyer confusion over AI costs that stretched out decision cycles, and its own uneven go-to-market execution. A rebound toward double-digit total ACV growth, or even clear stabilization with PegaCloud holding above 20%, would validate the argument that deals were delayed rather than lost. Another leg down would suggest the problem is structural and not merely a frozen quarter.
Management also pointed to late-stage and new-logo pipelines that were up strongly year over year. This quarter should begin to reveal whether that pipeline converts. Investors will want evidence that the July launch of Infinity 26 and Infinity Studio, which push Blueprint AI into building and evolving applications, is translating into signed deals, and that Pega's pricing model without per-token charges is winning over customers nervous about runaway AI costs. Commentary on whether the self-admitted sales execution issues have been addressed will carry as much weight as any single metric.
Cash flow is the other pillar. The company produced a record $288 million in first-half free cash flow and bought back roughly $360 million of stock. Any update on the $575 million target, and on the promise to re-evaluate investment priorities, will signal how much confidence management has in the second half. Holding that target would be reassuring; trimming it would confirm the ACV weakness is bleeding into cash.
Sentiment has soured noticeably, with bearish readings climbing to about 52% from roughly 17% ahead of the last report, even as the stock rallied. Shares at $35.65 sit below the 200-day moving average near $39 and several percent shy of the post-earnings high of $38.96, so the rebound has not yet turned into a breakout. That tension frames the report neatly. The central question is whether ACV growth has stopped falling. If it has, the rally looks justified; if not, the 40% bounce rests on hope rather than evidence.